Medicare Coverage Determinations for Genetic Tests
As of May 2022 the Centers for Medicare and Medicaid has over 100 active LCDs and Articles pertaining to Genetics. There are new potential Local Coverage Determinations and Articles that will be published in the future.
ID (A for Article L for LCD) | Title | Type | Medicare Administrative Contractor |
---|---|---|---|
A57449 | Billing and Coding: BRCA1 and BRCA2 Genetic Testing | Article | First Coast Service Options, Inc. |
A56542 | Billing and Coding: BRCA1 and BRCA2 Genetic Testing | Article | Novitas Solutions, Inc. |
A58797 | Billing and Coding: Genetic Testing for Cardiovascular Disease | Article | First Coast Service Options, Inc. |
A58795 | Billing and Coding: Genetic Testing for Cardiovascular Disease | Article | Novitas Solutions, Inc. |
A57450 | Billing and Coding: Genetic Testing for Lynch Syndrome | Article | First Coast Service Options, Inc. |
A56971 | Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing | Article | CGS Administrators, LLC |
A57354 | Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A57355 | Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A56854 | Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing | Article | Palmetto GBA |
A57771 | Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A54878 | Billing and Coding: MolDX: CDH1 Genetic Testing | Article | CGS Administrators, LLC |
A55970 | Billing and Coding: MolDX: CDH1 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55971 | Billing and Coding: MolDX: CDH1 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A54835 | Billing and Coding: MolDX: CDH1 Genetic Testing | Article | Palmetto GBA |
A55622 | Billing and Coding: MolDX: CDH1 Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A54263 | Billing and Coding: MolDX: FANCC Genetic Testing | Article | CGS Administrators, LLC |
A55183 | Billing and Coding: MolDX: FANCC Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55184 | Billing and Coding: MolDX: FANCC Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A53628 | Billing and Coding: MolDX: FANCC Genetic Testing | Article | Palmetto GBA |
A55160 | Billing and Coding: MolDX: FANCC Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A54265 | Billing and Coding: MolDX: GBA Genetic Testing | Article | CGS Administrators, LLC |
A55243 | Billing and Coding: MolDX: GBA Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55244 | Billing and Coding: MolDX: GBA Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A53542 | Billing and Coding: MolDX: GBA Genetic Testing | Article | Palmetto GBA |
A55164 | Billing and Coding: MolDX: GBA Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A56999 | Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Article | CGS Administrators, LLC |
A57421 | Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Article | Noridian Healthcare Solutions, LLC |
A57422 | Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Article | Noridian Healthcare Solutions, LLC |
A56959 | Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Article | Palmetto GBA |
A57570 | Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Article | Wisconsin Physicians Service Insurance Corporation |
A56980 | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Article | CGS Administrators, LLC |
A57423 | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Article | Noridian Healthcare Solutions, LLC |
A57424 | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Article | Noridian Healthcare Solutions, LLC |
A56899 | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Article | Palmetto GBA |
A57571 | Billing and Coding: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | Article | Wisconsin Physicians Service Insurance Corporation |
A56882 | Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome | Article | CGS Administrators, LLC |
A54995 | Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome | Article | Noridian Healthcare Solutions, LLC |
A54996 | Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome | Article | Noridian Healthcare Solutions, LLC |
A54987 | Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome | Article | Palmetto GBA |
A55135 | Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome | Article | Wisconsin Physicians Service Insurance Corporation |
A54270 | Billing and Coding: MolDX: IKBKAP Genetic Testing | Article | CGS Administrators, LLC |
A55612 | Billing and Coding: MolDX: IKBKAP Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55613 | Billing and Coding: MolDX: IKBKAP Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A53596 | Billing and Coding: MolDX: IKBKAP Genetic Testing | Article | Palmetto GBA |
A55170 | Billing and Coding: MolDX: IKBKAP Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A55283 | Billing and Coding: MolDX: MCOLN1 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55284 | Billing and Coding: MolDX: MCOLN1 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A53630 | Billing and Coding: MolDX: MCOLN1 Genetic Testing | Article | Palmetto GBA |
A55176 | Billing and Coding: MolDX: MCOLN1 Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A54277 | Billing and Coding: MolDX: MCOLN1 Genetic Testing Guidelines | Article | CGS Administrators, LLC |
A53574 | Billing and Coding: MolDX: MECP2 Genetic | Article | Palmetto GBA |
A54278 | Billing and Coding: MolDX: MECP2 Genetic Testing | Article | CGS Administrators, LLC |
A55285 | Billing and Coding: MolDX: MECP2 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55286 | Billing and Coding: MolDX: MECP2 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55189 | Billing and Coding: MolDX: MECP2 Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A56998 | Billing and Coding: MolDX: NRAS Genetic Testing | Article | CGS Administrators, LLC |
A57486 | Billing and Coding: MolDX: NRAS Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A57487 | Billing and Coding: MolDX: NRAS Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A56962 | Billing and Coding: MolDX: NRAS Genetic Testing | Article | Palmetto GBA |
A57581 | Billing and Coding: MolDX: NRAS Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A54285 | Billing and Coding: MolDX: SMPD1 Genetic Testing | Article | CGS Administrators, LLC |
A55627 | Billing and Coding: MolDX: SMPD1 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55631 | Billing and Coding: MolDX: SMPD1 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A53624 | Billing and Coding: MolDX: SMPD1 Genetic Testing | Article | Palmetto GBA |
A55208 | Billing and Coding: MolDX: SMPD1 Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A54283 | Billing and Coding: MolDX: SULT4A1 Genetic Testing | Article | CGS Administrators, LLC |
A55596 | Billing and Coding: MolDX: SULT4A1 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55601 | Billing and Coding: MolDX: SULT4A1 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A53538 | Billing and Coding: MolDX: SULT4A1 Genetic Testing | Article | Palmetto GBA |
A55210 | Billing and Coding: MolDX: SULT4A1 Genetic Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A58918 | Billing and Coding: Molecular Pathology and Genetic Testing | Article | First Coast Service Options, Inc. |
A58917 | Billing and Coding: Molecular Pathology and Genetic Testing | Article | Novitas Solutions, Inc. |
L36499 | BRCA1 and BRCA2 Genetic Testing | LCD | First Coast Service Options, Inc. |
L36715 | BRCA1 and BRCA2 Genetic Testing | LCD | Novitas Solutions, Inc. |
DL39084 (Comments Ended 09/11/2021) | Genetic Testing for Cardiovascular Disease | Proposed LCD | First Coast Service Options, Inc. |
L39084 | Genetic Testing for Cardiovascular Disease | LCD | First Coast Service Options, Inc. |
DL39082 (Comments Ended 09/11/2021) | Genetic Testing for Cardiovascular Disease | Proposed LCD | Novitas Solutions, Inc. |
L39082 | Genetic Testing for Cardiovascular Disease | LCD | Novitas Solutions, Inc. |
L34912 | Genetic Testing for Lynch Syndrome | LCD | First Coast Service Options, Inc. |
L36456 | MolDX: BRCA1 and BRCA2 Genetic Testing | LCD | CGS Administrators, LLC |
L36161 | MolDX: BRCA1 and BRCA2 Genetic Testing | LCD | Noridian Healthcare Solutions, LLC |
L36163 | MolDX: BRCA1 and BRCA2 Genetic Testing | LCD | Noridian Healthcare Solutions, LLC |
L36082 | MolDX: BRCA1 and BRCA2 Genetic Testing | LCD | Palmetto GBA |
L36813 | MolDX: BRCA1 and BRCA2 Genetic Testing | LCD | Wisconsin Physicians Service Insurance Corporation |
L36117 | MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | LCD | CGS Administrators, LLC |
L36180 | MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | LCD | Noridian Healthcare Solutions, LLC |
L36186 | MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | LCD | Noridian Healthcare Solutions, LLC |
L36044 | MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | LCD | Palmetto GBA |
L36815 | MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | LCD | Wisconsin Physicians Service Insurance Corporation |
L35984 | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | LCD | CGS Administrators, LLC |
L36155 | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | LCD | Noridian Healthcare Solutions, LLC |
L36159 | MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | LCD | Noridian Healthcare Solutions, LLC |
L36089 | MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | LCD | Palmetto GBA |
L36400 | MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) | LCD | Wisconsin Physicians Service Insurance Corporation |
L35349 | MolDX: Genetic Testing for Lynch Syndrome | LCD | CGS Administrators, LLC |
L36370 | MolDX: Genetic Testing for Lynch Syndrome | LCD | Noridian Healthcare Solutions, LLC |
L36374 | MolDX: Genetic Testing for Lynch Syndrome | LCD | Noridian Healthcare Solutions, LLC |
L35024 | MolDX: Genetic Testing for Lynch Syndrome | LCD | Palmetto GBA |
L36793 | MolDX: Genetic Testing for Lynch Syndrome | LCD | Wisconsin Physicians Service Insurance Corporation |
L35442 | MolDX: NRAS Genetic Testing | LCD | CGS Administrators, LLC |
L36335 | MolDX: NRAS Genetic Testing | LCD | Noridian Healthcare Solutions, LLC |
L36339 | MolDX: NRAS Genetic Testing | LCD | Noridian Healthcare Solutions, LLC |
L35073 | MolDX: NRAS Genetic Testing | LCD | Palmetto GBA |
L36797 | MolDX: NRAS Genetic Testing | LCD | Wisconsin Physicians Service Insurance Corporation |
A54612 | Response to Comments for MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Article | CGS Administrators, LLC |
A55806 | Response to Comments: BRCA1 and BRCA2 Genetic Testing | Article | First Coast Service Options, Inc. |
A58956 | Response to Comments: Genetic Testing for Cardiovascular Disease | Article | First Coast Service Options, Inc. |
A58955 | Response to Comments: Genetic Testing for Cardiovascular Disease | Article | Novitas Solutions, Inc. |
A54921 | Response to Comments: Genetic Testing for CYP2C19, CYP2D6, CYP2C9, and VKORC1 (L36398). | Article | Wisconsin Physicians Service Insurance Corporation |
A54920 | Response to Comments: Genetic Testing for Hypercoagulability /Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) L36400 (A54920) | Article | Wisconsin Physicians Service Insurance Corporation |
A55385 | Response to Comments: MolDX-05: Breast Cancer Index℠ Genetic Assay (L36785) | Article | Wisconsin Physicians Service Insurance Corporation |
A54897 | Response to Comments: MolDX: BRCA1 and BRCA 2 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A54898 | Response to Comments: MolDX: BRCA1 and BRCA 2 Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A54814 | Response to Comments: MolDX: BRCA1 and BRCA2 Genetic Testing | Article | CGS Administrators, LLC |
A55386 | Response to Comments: MolDX: BRCA1 and BRCA2 Genetic Testing (L36813) | Article | Wisconsin Physicians Service Insurance Corporation |
A56068 | Response to Comments: MolDX: Breast Cancer IndexSM Genetic Assay | Article | Palmetto GBA |
A54916 | Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Article | Noridian Healthcare Solutions, LLC |
A54927 | Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease | Article | Noridian Healthcare Solutions, LLC |
A55397 | Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36815) | Article | Wisconsin Physicians Service Insurance Corporation |
A54893 | Response to Comments: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia | Article | Noridian Healthcare Solutions, LLC |
A54894 | Response to Comments: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia | Article | Noridian Healthcare Solutions, LLC |
A54964 | Response to Comments: MolDX: Genetic Testing for Lynch Syndrome | Article | Noridian Healthcare Solutions, LLC |
A54965 | Response to Comments: MolDX: Genetic Testing for Lynch Syndrome | Article | Noridian Healthcare Solutions, LLC |
A56361 | Response to Comments: MolDX: Genetic Testing for Lynch Syndrome | Article | Noridian Healthcare Solutions, LLC |
A56362 | Response to Comments: MolDX: Genetic Testing for Lynch Syndrome | Article | Noridian Healthcare Solutions, LLC |
A55399 | Response to Comments: MolDX: Genetic Testing for Lynch Syndrome (L36793) | Article | Wisconsin Physicians Service Insurance Corporation |
A54881 | Response to Comments: MolDX: HLA-B*15:02 Genetic Testing | Article | CGS Administrators, LLC |
A55380 | Response to Comments: MolDX: HLA-B*15:02 Genetic Testing (L36801) | Article | Wisconsin Physicians Service Insurance Corporation |
A55048 | Response to Comments: MolDX: NRAS Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55049 | Response to Comments: MolDX: NRAS Genetic Testing | Article | Noridian Healthcare Solutions, LLC |
A55400 | Response to Comments: MolDX: NRAS Genetic Testing (L36797) | Article | Wisconsin Physicians Service Insurance Corporation |
L35395 | Autonomic Function Tests | LCD | Novitas Solutions, Inc. |
A56526 | Billing and Coding: 3D Interpretation and Reporting of Imaging Studies | Article | Novitas Solutions, Inc. |
A56485 | Billing and Coding: Assays for Vitamins and Metabolic Function | Article | Palmetto GBA |
A56589 | Billing and Coding: Barium Swallow Studies, Modified | Article | Novitas Solutions, Inc. |
A52986 | Billing and Coding: Biomarkers for Oncology | Article | Novitas Solutions, Inc. |
A57474 | Billing and Coding: Botulinum Toxin Type A & Type B | Article | Wisconsin Physicians Service Insurance Corporation |
A57186 | Billing and Coding: Botulinum Toxin Types A and B | Article | Noridian Healthcare Solutions, LLC |
A57185 | Billing and Coding: Botulinum Toxin Types A and B Policy | Article | Noridian Healthcare Solutions, LLC |
A56472 | Billing and Coding: Botulinum Toxins | Article | CGS Administrators, LLC |
A52848 | Billing and Coding: Botulinum Toxins | Article | National Government Services, Inc. |
A56646 | Billing and Coding: Chemodenervation | Article | Palmetto GBA |
A52378 | Billing and Coding: Colorectal Cancer Screening – Medical Policy Article | Article | National Government Services, Inc. |
A58774 | Billing and Coding: Cosmetic and Reconstructive Surgery | Article | Wisconsin Physicians Service Insurance Corporation |
A56612 | Billing and Coding: CT of the Head | Article | Palmetto GBA |
A56464 | Billing and Coding: Flow Cytometry | Article | CGS Administrators, LLC |
A57716 | Billing and Coding: Flow Cytometry | Article | First Coast Service Options, Inc. |
A56676 | Billing and Coding: Flow Cytometry | Article | Novitas Solutions, Inc. |
A56867 | Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms | Article | National Government Services, Inc. |
A58192 | Billing and Coding: Guardant360® | Article | Noridian Healthcare Solutions, LLC |
A58214 | Billing and Coding: Guardant360® | Article | Noridian Healthcare Solutions, LLC |
A56326 | Billing and Coding: Implantable Automatic Defibrillators | Article | National Government Services, Inc. |
A56340 | Billing and Coding: Implantable Automatic Defibrillators | Article | Noridian Healthcare Solutions, LLC |
A56342 | Billing and Coding: Implantable Automatic Defibrillators | Article | Noridian Healthcare Solutions, LLC |
A56343 | Billing and Coding: Implantable Automatic Defibrillators | Article | Palmetto GBA |
A56391 | Billing and Coding: Implantable Automatic Defibrillators | Article | Wisconsin Physicians Service Insurance Corporation |
A57689 | Billing and Coding: Lab: Flow Cytometry | Article | Noridian Healthcare Solutions, LLC |
A57690 | Billing and Coding: Lab: Flow Cytometry | Article | Noridian Healthcare Solutions, LLC |
A55717 | Billing and Coding: Lab: Flow Cytometry | Article | Palmetto GBA |
A54685 | Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing | Article | CGS Administrators, LLC |
A54975 | Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing | Article | Noridian Healthcare Solutions, LLC |
A54976 | Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing | Article | Noridian Healthcare Solutions, LLC |
A53605 | Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing | Article | Palmetto GBA |
A55235 | Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A55088 | Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) Testing | Article | Noridian Healthcare Solutions, LLC |
A55089 | Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) Testing | Article | Noridian Healthcare Solutions, LLC |
A55142 | Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency (ASPA) Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A54253 | Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency(ASPA) Testing | Article | CGS Administrators, LLC |
A53602 | Billing and Coding: MolDX: Aspartoacyclase 2 Deficiency(ASPA) Testing | Article | Palmetto GBA |
A54254 | Billing and Coding: MolDX: ATP7B Gene Tests | Article | CGS Administrators, LLC |
A55097 | Billing and Coding: MolDX: ATP7B Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A55098 | Billing and Coding: MolDX: ATP7B Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A53550 | Billing and Coding: MolDX: ATP7B Gene Tests | Article | Palmetto GBA |
A55143 | Billing and Coding: MolDX: ATP7B Gene Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A54255 | Billing and Coding: MolDX: BCKDHB Gene Test | Article | CGS Administrators, LLC |
A55099 | Billing and Coding: MolDX: BCKDHB Gene Test | Article | Noridian Healthcare Solutions, LLC |
A55100 | Billing and Coding: MolDX: BCKDHB Gene Test | Article | Noridian Healthcare Solutions, LLC |
A53600 | Billing and Coding: MolDX: BCKDHB Gene Test | Article | Palmetto GBA |
A55145 | Billing and Coding: MolDX: BCKDHB Gene Test | Article | Wisconsin Physicians Service Insurance Corporation |
A54256 | Billing and Coding: MolDX: BLM Gene Analysis | Article | CGS Administrators, LLC |
A55113 | Billing and Coding: MolDX: BLM Gene Analysis | Article | Noridian Healthcare Solutions, LLC |
A55114 | Billing and Coding: MolDX: BLM Gene Analysis | Article | Noridian Healthcare Solutions, LLC |
A53540 | Billing and Coding: MolDX: BLM Gene Analysis | Article | Palmetto GBA |
A55148 | Billing and Coding: MolDX: BLM Gene Analysis | Article | Wisconsin Physicians Service Insurance Corporation |
A54262 | Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests | Article | CGS Administrators, LLC |
A55181 | Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A55182 | Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A53536 | Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests | Article | Palmetto GBA |
A55159 | Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A54191 | Billing and Coding: MolDX: FDA-Approved BRAF Tests | Article | CGS Administrators, LLC |
A54418 | Billing and Coding: MolDX: FDA-Approved BRAF Tests | Article | Noridian Healthcare Solutions, LLC |
A54420 | Billing and Coding: MolDX: FDA-Approved BRAF Tests | Article | Noridian Healthcare Solutions, LLC |
A54018 | Billing and Coding: MolDX: FDA-Approved BRAF Tests | Article | Palmetto GBA |
A55161 | Billing and Coding: MolDX: FDA-Approved BRAF Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A54192 | Billing and Coding: MolDX: FDA-Approved EGFR Tests | Article | CGS Administrators, LLC |
A54422 | Billing and Coding: MolDX: FDA-Approved EGFR Tests | Article | Noridian Healthcare Solutions, LLC |
A54424 | Billing and Coding: MolDX: FDA-Approved EGFR Tests | Article | Noridian Healthcare Solutions, LLC |
A54021 | Billing and Coding: MolDX: FDA-Approved EGFR Tests | Article | Palmetto GBA |
A55193 | Billing and Coding: MolDX: FDA-Approved EGFR Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A54688 | Billing and Coding: MolDX: FDA-Approved KRAS Tests | Article | CGS Administrators, LLC |
A54498 | Billing and Coding: MolDX: FDA-Approved KRAS Tests | Article | Noridian Healthcare Solutions, LLC |
A54500 | Billing and Coding: MolDX: FDA-Approved KRAS Tests | Article | Noridian Healthcare Solutions, LLC |
A54472 | Billing and Coding: MolDX: FDA-Approved KRAS Tests | Article | Palmetto GBA |
A55162 | Billing and Coding: MolDX: FDA-Approved KRAS Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A54267 | Billing and Coding: MolDX: HBB Gene Tests | Article | CGS Administrators, LLC |
A55253 | Billing and Coding: MolDX: HBB Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A55254 | Billing and Coding: MolDX: HBB Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A53493 | Billing and Coding: MolDX: HBB Gene Tests | Article | Palmetto GBA |
A55166 | Billing and Coding: MolDX: HBB Gene Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A54268 | Billing and Coding: MolDX: HEXA Gene Analysis | Article | CGS Administrators, LLC |
A55255 | Billing and Coding: MolDX: HEXA Gene Analysis | Article | Noridian Healthcare Solutions, LLC |
A55256 | Billing and Coding: MolDX: HEXA Gene Analysis | Article | Noridian Healthcare Solutions, LLC |
A53598 | Billing and Coding: MolDX: HEXA Gene Analysis | Article | Palmetto GBA |
A55168 | Billing and Coding: MolDX: HEXA Gene Analysis | Article | Wisconsin Physicians Service Insurance Corporation |
A55277 | Billing and Coding: MolDX: L1CAM Gene Sequencing | Article | Noridian Healthcare Solutions, LLC |
A55278 | Billing and Coding: MolDX: L1CAM Gene Sequencing | Article | Noridian Healthcare Solutions, LLC |
A53659 | Billing and Coding: MolDX: L1CAM Gene Sequencing | Article | Palmetto GBA |
A55192 | Billing and Coding: MolDX: L1CAM Gene Sequencing | Article | Wisconsin Physicians Service Insurance Corporation |
A54274 | Billing and Coding: MolDX: L1CAM Gene Sequencing Guidelines | Article | CGS Administrators, LLC |
A58998 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers | Article | CGS Administrators, LLC |
A58996 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers | Article | Noridian Healthcare Solutions, LLC |
A58997 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers | Article | Noridian Healthcare Solutions, LLC |
A58988 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers | Article | Palmetto GBA |
A59004 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers | Article | Wisconsin Physicians Service Insurance Corporation |
A58434 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers | Article | CGS Administrators, LLC |
A58454 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers | Article | Noridian Healthcare Solutions, LLC |
A58456 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers | Article | Noridian Healthcare Solutions, LLC |
A58376 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers | Article | Palmetto GBA |
A58468 | Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers | Article | Wisconsin Physicians Service Insurance Corporation |
A55290 | Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A55291 | Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A53669 | Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests | Article | Palmetto GBA |
A55190 | Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A54288 | Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests Guidelines | Article | CGS Administrators, LLC |
A56973 | Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) | Article | CGS Administrators, LLC |
A57526 | Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) | Article | Noridian Healthcare Solutions, LLC |
A57527 | Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) | Article | Noridian Healthcare Solutions, LLC |
A56853 | Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) | Article | Palmetto GBA |
A57772 | Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) | Article | Wisconsin Physicians Service Insurance Corporation |
A54689 | Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx® | Article | CGS Administrators, LLC |
A55294 | Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx® | Article | Noridian Healthcare Solutions, LLC |
A55295 | Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx® | Article | Noridian Healthcare Solutions, LLC |
A54338 | Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx® | Article | Palmetto GBA |
A55224 | Billing and Coding: MolDX: Myriad’s BRACAnalysis CDx® | Article | Wisconsin Physicians Service Insurance Corporation |
A54291 | Billing and Coding: MolDX: NSD1 Gene Tests | Article | CGS Administrators, LLC |
A55609 | Billing and Coding: MolDX: NSD1 Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A55615 | Billing and Coding: MolDX: NSD1 Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A53585 | Billing and Coding: MolDX: NSD1 Gene Tests | Article | Palmetto GBA |
A55198 | Billing and Coding: MolDX: NSD1 Gene Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A55625 | Billing and Coding: MolDX: PAX6 Gene Sequencing | Article | Noridian Healthcare Solutions, LLC |
A55632 | Billing and Coding: MolDX: PAX6 Gene Sequencing | Article | Noridian Healthcare Solutions, LLC |
A53664 | Billing and Coding: MolDX: PAX6 Gene Sequencing | Article | Palmetto GBA |
A55199 | Billing and Coding: MolDX: PAX6 Gene Sequencing | Article | Wisconsin Physicians Service Insurance Corporation |
A54293 | Billing and Coding: MolDX: PAX6 Gene Sequencing Guidelines | Article | CGS Administrators, LLC |
A57141 | Billing and Coding: MolDX: Repeat Germline Testing | Article | CGS Administrators, LLC |
A57331 | Billing and Coding: MolDX: Repeat Germline Testing | Article | Noridian Healthcare Solutions, LLC |
A57332 | Billing and Coding: MolDX: Repeat Germline Testing | Article | Noridian Healthcare Solutions, LLC |
A58017 | Billing and Coding: MolDX: Repeat Germline Testing | Article | Palmetto GBA |
A57100 | Billing and Coding: MolDX: Repeat Germline Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A54299 | Billing and Coding: MolDX: RPS19 Gene Tests | Article | CGS Administrators, LLC |
A55610 | Billing and Coding: MolDX: RPS19 Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A55614 | Billing and Coding: MolDX: RPS19 Gene Tests | Article | Noridian Healthcare Solutions, LLC |
A53587 | Billing and Coding: MolDX: RPS19 Gene Tests | Article | Palmetto GBA |
A55205 | Billing and Coding: MolDX: RPS19 Gene Tests | Article | Wisconsin Physicians Service Insurance Corporation |
A57910 | Billing and Coding: MolDX: Testing of Multiple Genes | Article | CGS Administrators, LLC |
A58120 | Billing and Coding: MolDX: Testing of Multiple Genes | Article | Noridian Healthcare Solutions, LLC |
A58121 | Billing and Coding: MolDX: Testing of Multiple Genes | Article | Noridian Healthcare Solutions, LLC |
A57503 | Billing and Coding: MolDX: Testing of Multiple Genes | Article | Palmetto GBA |
A57880 | Billing and Coding: MolDX: Testing of Multiple Genes | Article | Wisconsin Physicians Service Insurance Corporation |
A54200 | Billing and Coding: MolDX: therascreen® KRAS PCR Kit Guidelines | Article | CGS Administrators, LLC |
A57451 | Billing and Coding: Molecular Pathology Procedures | Article | First Coast Service Options, Inc. |
A56199 | Billing and Coding: Molecular Pathology Procedures | Article | National Government Services, Inc. |
A57361 | Billing and Coding: Monitored Anesthesia Care | Article | Novitas Solutions, Inc. |
A57204 | Billing and Coding: MRI and CT Scans of the Head and Neck | Article | Noridian Healthcare Solutions, LLC |
A57215 | Billing and Coding: MRI and CT Scans of the Head and Neck | Article | Noridian Healthcare Solutions, LLC |
A57307 | Billing and Coding: Nerve Conduction Studies and Electromyography | Article | CGS Administrators, LLC |
A57123 | Billing and Coding: Nerve Conduction Studies and Electromyography | Article | First Coast Service Options, Inc. |
A57668 | Billing and Coding: Nerve Conduction Studies and Electromyography | Article | National Government Services, Inc. |
A54969 | Billing and Coding: Nerve Conduction Studies and Electromyography | Article | Noridian Healthcare Solutions, LLC |
A54992 | Billing and Coding: Nerve Conduction Studies and Electromyography | Article | Noridian Healthcare Solutions, LLC |
A54095 | Billing and Coding: Nerve Conduction Studies and Electromyography | Article | Novitas Solutions, Inc. |
A56619 | Billing and Coding: Nerve Conduction Studies and Electromyography | Article | Palmetto GBA |
A57478 | Billing and Coding: Nerve Conduction Studies and Electromyography | Article | Wisconsin Physicians Service Insurance Corporation |
A56773 | Billing and Coding: Neurophysiology Evoked Potentials (NEPs) | Article | Novitas Solutions, Inc. |
A58812 | Billing and Coding: Pharmacogenomics Testing | Article | First Coast Service Options, Inc. |
A58801 | Billing and Coding: Pharmacogenomics Testing | Article | Novitas Solutions, Inc. |
A57130 | Billing and Coding: Psychiatric Codes | Article | Novitas Solutions, Inc. |
A57052 | Billing and Coding: Psychiatric Inpatient Hospitalization | Article | CGS Administrators, LLC |
A56865 | Billing and Coding: Psychiatric Inpatient Hospitalization | Article | National Government Services, Inc. |
A57053 | Billing and Coding: Psychiatric Partial Hospitalization Programs | Article | CGS Administrators, LLC |
A57780 | Billing and Coding: Psychological and Neuropsychological Tests | Article | First Coast Service Options, Inc. |
A54111 | Billing and Coding: Speech Language Pathology (SLP) Services: Communication Disorders | Article | Novitas Solutions, Inc. |
A56802 | Billing and Coding: Urodynamics | Article | CGS Administrators, LLC |
A57455 | Billing and Coding: Urodynamics | Article | National Government Services, Inc. |
A57434 | Billing and Coding: Vestibular and Audiologic Function Studies | Article | Novitas Solutions, Inc. |
L37851 | Biomarker Testing for Neuroendocrine Tumors/Neoplasms | LCD | National Government Services, Inc. |
L35396 | Biomarkers for Oncology | LCD | Novitas Solutions, Inc. |
L35062 | Biomarkers Overview | LCD | Novitas Solutions, Inc. |
L33270 | Bisphosphonates (Intravenous [IV]) and Monoclonal Antibodies in the Treatment of Osteoporosis and Their Other Indications | LCD | First Coast Service Options, Inc. |
L36356 | Bone Mineral Density Studies | LCD | First Coast Service Options, Inc. |
L34856 | C-Reactive Protein High Sensitivity Testing (hsCRP) | LCD | Novitas Solutions, Inc. |
L37126 | Coenzyme Q10 (CoQ10) | LCD | CGS Administrators, LLC |
L34213 | Diagnostic and Therapeutic Colonoscopy | LCD | Noridian Healthcare Solutions, LLC |
L36868 | Diagnostic and Therapeutic Colonoscopy | LCD | Noridian Healthcare Solutions, LLC |
L37606 | Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases | LCD | National Government Services, Inc. |
DL37810 (Comments Ended 11/13/2021) | Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms | Proposed LCD | National Government Services, Inc. |
L37810 (Notice Ended 03/31/2022) | Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms | LCD | National Government Services, Inc. |
A52434 | Health and Behavior Assessment/Intervention – Medical Policy Article | Article | National Government Services, Inc. |
L33684 | Hemophilia Clotting Factors | LCD | First Coast Service Options, Inc. |
L35427 | Hyaluronan Acid Therapies for Osteoarthritis of the Knee | LCD | Novitas Solutions, Inc. |
L34007 | Intravenous Immune Globulin | LCD | First Coast Service Options, Inc. |
L34580 | Intravenous Immunoglobulin (IVIG) | LCD | Palmetto GBA |
L37066 | Lab: Coenzyme Q10 (CoQ10) | LCD | Noridian Healthcare Solutions, LLC |
L37068 | Lab: Coenzyme Q10 (CoQ10) | LCD | Noridian Healthcare Solutions, LLC |
L37022 | Lab: Coenzyme Q10 (CoQ10) | LCD | Palmetto GBA |
L34215 | Lab: Flow Cytometry | LCD | Noridian Healthcare Solutions, LLC |
L36094 | Lab: Flow Cytometry | LCD | Noridian Healthcare Solutions, LLC |
L34513 | Lab: Flow Cytometry | LCD | Palmetto GBA |
L34864 | Loss-of-Heterozygosity Based Topographic Genotyping with PathfinderTG ® | LCD | Novitas Solutions, Inc. |
L37608 | MDS FISH | LCD | CGS Administrators, LLC |
L37620 | MDS FISH | LCD | Noridian Healthcare Solutions, LLC |
L37622 | MDS FISH | LCD | Noridian Healthcare Solutions, LLC |
L37602 | MDS FISH | LCD | Palmetto GBA |
L37772 | MDS FISH | LCD | Wisconsin Physicians Service Insurance Corporation |
L35702 | Mohs Micrographic Surgery | LCD | Noridian Healthcare Solutions, LLC |
L35704 | Mohs Micrographic Surgery | LCD | Noridian Healthcare Solutions, LLC |
L35494 | Mohs Micrographic Surgery | LCD | Wisconsin Physicians Service Insurance Corporation |
L33689 | Mohs Micrographic Surgery (MMS) | LCD | First Coast Service Options, Inc. |
L34961 | Mohs Micrographic Surgery (MMS) | LCD | Novitas Solutions, Inc. |
L38355 | MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart Allografts | LCD | Noridian Healthcare Solutions, LLC |
L38380 | MolDX: AlloSure® or Equivalent Cell-Free DNA Testing for Kidney and Heart Allografts | LCD | Noridian Healthcare Solutions, LLC |
L36910 | MolDX: APC and MUTYH Gene Testing | LCD | CGS Administrators, LLC |
L36882 | MolDX: APC and MUTYH Gene Testing | LCD | Noridian Healthcare Solutions, LLC |
L36884 | MolDX: APC and MUTYH Gene Testing | LCD | Noridian Healthcare Solutions, LLC |
L36827 | MolDX: APC and MUTYH Gene Testing | LCD | Palmetto GBA |
L37224 | MolDX: APC and MUTYH Gene Testing | LCD | Wisconsin Physicians Service Insurance Corporation |
L36139 | MolDX: Biomarkers in Cardiovascular Risk Assessment | LCD | CGS Administrators, LLC |
L36358 | MolDX: Biomarkers in Cardiovascular Risk Assessment | LCD | Noridian Healthcare Solutions, LLC |
L36362 | MolDX: Biomarkers in Cardiovascular Risk Assessment | LCD | Noridian Healthcare Solutions, LLC |
L36129 | MolDX: Biomarkers in Cardiovascular Risk Assessment | LCD | Palmetto GBA |
L36523 | MolDX: Biomarkers in Cardiovascular Risk Assessment | LCD | Wisconsin Physicians Service Insurance Corporation |
DL38997 (Comments Ended 08/07/2021) | MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Proposed LCD | CGS Administrators, LLC |
DL39005 (Comments Ended 07/03/2021) | MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL39007 (Comments Ended 07/03/2021) | MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL38985 (Comments Ended 07/03/2021) | MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Proposed LCD | Palmetto GBA |
DL39042 (Comments Ended 07/03/2021) | MolDX: Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Proposed LCD | Wisconsin Physicians Service Insurance Corporation |
L38249 | MolDX: Blood Product Molecular Antigen Typing | LCD | CGS Administrators, LLC |
L38331 | MolDX: Blood Product Molecular Antigen Typing | LCD | Noridian Healthcare Solutions, LLC |
L38333 | MolDX: Blood Product Molecular Antigen Typing | LCD | Noridian Healthcare Solutions, LLC |
L38240 | MolDX: Blood Product Molecular Antigen Typing | LCD | Palmetto GBA |
L38441 | MolDX: Blood Product Molecular Antigen Typing | LCD | Wisconsin Physicians Service Insurance Corporation |
L37832 | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | LCD | CGS Administrators, LLC |
L37822 | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | LCD | Noridian Healthcare Solutions, LLC |
L37824 | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | LCD | Noridian Healthcare Solutions, LLC |
L37794 | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | LCD | Palmetto GBA |
L37913 | MolDX: Breast Cancer Index® (BCI) Gene Expression Test | LCD | Wisconsin Physicians Service Insurance Corporation |
L37210 | MolDX: Decision Dx-UM (Uveal Melanoma) | LCD | Wisconsin Physicians Service Insurance Corporation |
L37130 | MolDX: DecisionDx-UM (Uveal Melanoma) | LCD | CGS Administrators, LLC |
L37070 | MolDX: DecisionDx-UM (Uveal Melanoma) | LCD | Noridian Healthcare Solutions, LLC |
L37072 | MolDX: DecisionDx-UM (Uveal Melanoma) | LCD | Noridian Healthcare Solutions, LLC |
L37033 | MolDX: DecisionDx-UM (Uveal Melanoma) | LCD | Palmetto GBA |
L37356 | MolDX: EndoPredict Breast Cancer Gene Expression Test | LCD | CGS Administrators, LLC |
L37264 | MolDX: EndoPredict Breast Cancer Gene Expression Test | LCD | Palmetto GBA |
DL37295 (Comments Ended 07/12/2020) | MolDX: EndoPredict® Breast Cancer Gene Expression Test | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL37311 (Comments Ended 07/12/2020) | MolDX: EndoPredict® Breast Cancer Gene Expression Test | Proposed LCD | Noridian Healthcare Solutions, LLC |
L37295 | MolDX: EndoPredict® Breast Cancer Gene Expression Test | LCD | Noridian Healthcare Solutions, LLC |
L37311 | MolDX: EndoPredict® Breast Cancer Gene Expression Test | LCD | Noridian Healthcare Solutions, LLC |
L37663 | MolDX: EndoPredict® Breast Cancer Gene Expression Test | LCD | Wisconsin Physicians Service Insurance Corporation |
L37905 | MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test | LCD | CGS Administrators, LLC |
L37887 | MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test | LCD | Noridian Healthcare Solutions, LLC |
L37891 | MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test | LCD | Noridian Healthcare Solutions, LLC |
L37857 | MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test | LCD | Palmetto GBA |
L37919 | MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test | LCD | Wisconsin Physicians Service Insurance Corporation |
L36485 | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | LCD | CGS Administrators, LLC |
L36544 | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | LCD | Noridian Healthcare Solutions, LLC |
L36551 | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | LCD | Noridian Healthcare Solutions, LLC |
L36464 | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | LCD | Palmetto GBA |
L37003 | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | LCD | Wisconsin Physicians Service Insurance Corporation |
L37903 | MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer | LCD | CGS Administrators, LLC |
L37897 | MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | LCD | Noridian Healthcare Solutions, LLC |
L37870 | MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | LCD | Palmetto GBA |
L37921 | MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer | LCD | Wisconsin Physicians Service Insurance Corporation |
L37899 | MolDX: Inivata™, InvisionFirst®, Liquid Biopsy for Patients with Lung Cancer | LCD | Noridian Healthcare Solutions, LLC |
DL38629 (Comments Ended 07/12/2020) | MolDX: Liquid Biopsies for Solid Organ Transplantation | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL38671 (Comments Ended 07/12/2020) | MolDX: Liquid Biopsies for Solid Organ Transplantation | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL38016 (Comments Ended 08/07/2021) | MolDX: Melanoma Risk Stratification Molecular Testing | Proposed LCD | CGS Administrators, LLC |
L38016 | MolDX: Melanoma Risk Stratification Molecular Testing | LCD | CGS Administrators, LLC |
DL37748 (Comments Ended 07/03/2021) | MolDX: Melanoma Risk Stratification Molecular Testing | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL37750 (Comments Ended 07/03/2021) | MolDX: Melanoma Risk Stratification Molecular Testing | Proposed LCD | Noridian Healthcare Solutions, LLC |
L37748 | MolDX: Melanoma Risk Stratification Molecular Testing | LCD | Noridian Healthcare Solutions, LLC |
L37750 | MolDX: Melanoma Risk Stratification Molecular Testing | LCD | Noridian Healthcare Solutions, LLC |
DL37725 (Comments Ended 07/03/2021) | MolDX: Melanoma Risk Stratification Molecular Testing | Proposed LCD | Palmetto GBA |
L37725 | MolDX: Melanoma Risk Stratification Molecular Testing | LCD | Palmetto GBA |
DL38018 (Comments Ended 07/03/2021) | MolDX: Melanoma Risk Stratification Molecular Testing | Proposed LCD | Wisconsin Physicians Service Insurance Corporation |
L38018 | MolDX: Melanoma Risk Stratification Molecular Testing | LCD | Wisconsin Physicians Service Insurance Corporation |
L36113 | MolDX: MGMT Promoter Methylation Analysis | LCD | CGS Administrators, LLC |
L36188 | MolDX: MGMT Promoter Methylation Analysis | LCD | Noridian Healthcare Solutions, LLC |
L36192 | MolDX: MGMT Promoter Methylation Analysis | LCD | Noridian Healthcare Solutions, LLC |
L35974 | MolDX: MGMT Promoter Methylation Analysis | LCD | Palmetto GBA |
L37001 | MolDX: MGMT Promoter Methylation Analysis | LCD | Wisconsin Physicians Service Insurance Corporation |
DL38822 (Comments Ended 11/15/2020) | MolDX: Minimal Residual Disease Testing for Cancer | Proposed LCD | CGS Administrators, LLC |
L38822 | MolDX: Minimal Residual Disease Testing for Cancer | LCD | CGS Administrators, LLC |
DL38814 (Comments Ended 11/22/2020) | MolDX: Minimal Residual Disease Testing for Cancer | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL38816 (Comments Ended 11/22/2020) | MolDX: Minimal Residual Disease Testing for Cancer | Proposed LCD | Noridian Healthcare Solutions, LLC |
L38814 | MolDX: Minimal Residual Disease Testing for Cancer | LCD | Noridian Healthcare Solutions, LLC |
L38816 | MolDX: Minimal Residual Disease Testing for Cancer | LCD | Noridian Healthcare Solutions, LLC |
DL38779 (Comments Ended 11/07/2020) | MolDX: Minimal Residual Disease Testing for Cancer | Proposed LCD | Palmetto GBA |
L38779 | MolDX: Minimal Residual Disease Testing for Cancer | LCD | Palmetto GBA |
DL38835 (Comments Ended 11/14/2020) | MolDX: Minimal Residual Disease Testing for Cancer | Proposed LCD | Wisconsin Physicians Service Insurance Corporation |
L38835 | MolDX: Minimal Residual Disease Testing for Cancer | LCD | Wisconsin Physicians Service Insurance Corporation |
DL39262 (Comments End 06/11/2022) | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL39264 (Comments End 06/11/2022) | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL39256 (Comments End 05/14/2022) | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Proposed LCD | Palmetto GBA |
L38582 | MolDX: Molecular Testing for Solid Organ Allograft Rejection | LCD | CGS Administrators, LLC |
L38629 | MolDX: Molecular Testing for Solid Organ Allograft Rejection | LCD | Noridian Healthcare Solutions, LLC |
L38671 | MolDX: Molecular Testing for Solid Organ Allograft Rejection | LCD | Noridian Healthcare Solutions, LLC |
L38568 | MolDX: Molecular Testing for Solid Organ Allograft Rejection | LCD | Palmetto GBA |
L38680 | MolDx: Molecular Testing for Solid Organ Allograft Rejection | LCD | Wisconsin Physicians Service Insurance Corporation |
L37907 | MolDX: myPath Melanoma Assay | LCD | CGS Administrators, LLC |
L37879 | MolDX: myPath® Melanoma Assay | LCD | Noridian Healthcare Solutions, LLC |
L37881 | MolDX: myPath® Melanoma Assay | LCD | Noridian Healthcare Solutions, LLC |
L37859 | MolDX: myPath® Melanoma Assay | LCD | Palmetto GBA |
L37923 | MolDX: myPath® Melanoma Assay | LCD | Wisconsin Physicians Service Insurance Corporation |
L38067 | MolDX: Next-Generation Sequencing for Solid Tumors | LCD | CGS Administrators, LLC |
L38119 | MolDX: Next-Generation Sequencing for Solid Tumors | LCD | Noridian Healthcare Solutions, LLC |
L38121 | MolDX: Next-Generation Sequencing for Solid Tumors | LCD | Noridian Healthcare Solutions, LLC |
L38045 | MolDX: Next-Generation Sequencing for Solid Tumors | LCD | Palmetto GBA |
L38158 | MolDX: Next-Generation Sequencing for Solid Tumors | LCD | Wisconsin Physicians Service Insurance Corporation |
DL39017 (Comments Ended 08/07/2021) | MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes | Proposed LCD | CGS Administrators, LLC |
DL38972 (Comments Ended 07/03/2021) | MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL38974 (Comments Ended 07/03/2021) | MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL38966 (Comments Ended 07/31/2021) | MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes | Proposed LCD | Palmetto GBA |
DL39040 (Comments Ended 07/03/2021) | MolDX: Next-Generation Sequencing Lab-Developed Tests for Inherited Cancer Syndromes | Proposed LCD | Wisconsin Physicians Service Insurance Corporation |
L38070 | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | LCD | CGS Administrators, LLC |
L38123 | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | LCD | Noridian Healthcare Solutions, LLC |
L38125 | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | LCD | Noridian Healthcare Solutions, LLC |
L38047 | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | LCD | Palmetto GBA |
L38176 | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | LCD | Wisconsin Physicians Service Insurance Corporation |
L38394 | MolDX: Pharmacogenomics Testing | LCD | CGS Administrators, LLC |
L38335 | MolDX: Pharmacogenomics Testing | LCD | Noridian Healthcare Solutions, LLC |
L38337 | MolDX: Pharmacogenomics Testing | LCD | Noridian Healthcare Solutions, LLC |
L38294 | MolDX: Pharmacogenomics Testing | LCD | Palmetto GBA |
L38435 | MolDX: Pharmacogenomics Testing | LCD | Wisconsin Physicians Service Insurance Corporation |
L38584 | MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells | LCD | CGS Administrators, LLC |
L38643 | MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells | LCD | Noridian Healthcare Solutions, LLC |
L38645 | MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells | LCD | Noridian Healthcare Solutions, LLC |
L38678 | MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells | LCD | Wisconsin Physicians Service Insurance Corporation |
DL38643 (Comments Ended 07/12/2020) | MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL38645 (Comments Ended 07/12/2020) | MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells | Proposed LCD | Noridian Healthcare Solutions, LLC |
L38566 | MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells | LCD | Palmetto GBA |
DL38678 (Comments Ended 07/11/2020) | MolDX: Phenotypic Biomarker Detection in Circulating Tumor Cells | Proposed LCD | Wisconsin Physicians Service Insurance Corporation |
L38111 | MolDX: Pigmented Lesion Assay | LCD | CGS Administrators, LLC |
L38151 | MolDX: Pigmented Lesion Assay | LCD | Noridian Healthcare Solutions, LLC |
L38153 | MolDX: Pigmented Lesion Assay | LCD | Noridian Healthcare Solutions, LLC |
L38051 | MolDX: Pigmented Lesion Assay | LCD | Palmetto GBA |
L38178 | MolDX: Pigmented Lesion Assay | LCD | Wisconsin Physicians Service Insurance Corporation |
L38065 | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | LCD | CGS Administrators, LLC |
DL39230 (Comments Ended 03/05/2022) | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Proposed LCD | Noridian Healthcare Solutions, LLC |
DL39232 (Comments Ended 03/05/2022) | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Proposed LCD | Noridian Healthcare Solutions, LLC |
L38043 | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | LCD | Palmetto GBA |
L38168 | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | LCD | Wisconsin Physicians Service Insurance Corporation |
L38284 | MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer | LCD | CGS Administrators, LLC |
L38327 | MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | LCD | Noridian Healthcare Solutions, LLC |
L38329 | MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | LCD | Noridian Healthcare Solutions, LLC |
L38238 | MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | LCD | Palmetto GBA |
L38443 | MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | LCD | Wisconsin Physicians Service Insurance Corporation |
L38586 | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | LCD | CGS Administrators, LLC |
L38647 | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | LCD | Noridian Healthcare Solutions, LLC |
L38649 | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | LCD | Noridian Healthcare Solutions, LLC |
L38576 | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | LCD | Palmetto GBA |
DL38684 (Comments Ended 07/11/2020) | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Proposed LCD | Wisconsin Physicians Service Insurance Corporation |
L38684 | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | LCD | Wisconsin Physicians Service Insurance Corporation |
L37352 | MolDX: Prometheus IBD sgi Diagnostic® Policy | LCD | CGS Administrators, LLC |
L37299 | MolDX: Prometheus IBD sgi Diagnostic® Policy | LCD | Noridian Healthcare Solutions, LLC |
L37313 | MolDX: Prometheus IBD sgi Diagnostic® Policy | LCD | Noridian Healthcare Solutions, LLC |
L37260 | MolDX: Prometheus IBD sgi Diagnostic® Policy | LCD | Palmetto GBA |
L37539 | MolDX: Prometheus IBD sgi Diagnostic® Policy | LCD | Wisconsin Physicians Service Insurance Corporation |
L38303 | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | LCD | CGS Administrators, LLC |
L38339 | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | LCD | Noridian Healthcare Solutions, LLC |
L38341 | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | LCD | Noridian Healthcare Solutions, LLC |
L38292 | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | LCD | Palmetto GBA |
L38433 | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | LCD | Wisconsin Physicians Service Insurance Corporation |
L38288 | MolDX: Repeat Germline Testing | LCD | CGS Administrators, LLC |
L38351 | MolDX: Repeat Germline Testing | LCD | Noridian Healthcare Solutions, LLC |
L38353 | MolDX: Repeat Germline Testing | LCD | Noridian Healthcare Solutions, LLC |
L38274 | MolDX: Repeat Germline Testing | LCD | Palmetto GBA |
L38429 | MolDX: Repeat Germline Testing | LCD | Wisconsin Physicians Service Insurance Corporation |
L34519 | Molecular Pathology Procedures | LCD | First Coast Service Options, Inc. |
L35000 | Molecular Pathology Procedures | LCD | National Government Services, Inc. |
L34518 | Molecular Pathology Procedures for Human Leukocyte Antigen (HLA) Typing | LCD | First Coast Service Options, Inc. |
DL39226 (Comments Ended 03/26/2022) | Multiplex Gastrointestinal Pathogen Panel (GPP) Tests for Acute Gastroenteritis (AGE) | Proposed LCD | National Government Services, Inc. |
A53848 | NCD - Pharmacogenomic Testing for Warfarin Response | Article | First Coast Service Options, Inc. |
DL33370 (Comments Ended 11/13/2021) | Nebulizers | Proposed LCD | CGS Administrators, LLC, Noridian Healthcare Solutions, LLC |
L38920 | Off-label Use of Rituximab and Rituximab Biosimilars | LCD | CGS Administrators, LLC |
A55653 | Parenteral Iron Administration Coverage in Non-Dialysis Usage | Article | Noridian Healthcare Solutions, LLC |
A55734 | Parenteral Iron Administration Coverage in Non-Dialysis Usage | Article | Noridian Healthcare Solutions, LLC |
DL39073 (Comments Ended 07/24/2021) | Pharmacogenomics Testing | Proposed LCD | First Coast Service Options, Inc. |
L39073 | Pharmacogenomics Testing | LCD | First Coast Service Options, Inc. |
DL39063 (Comments Ended 07/24/2021) | Pharmacogenomics Testing | Proposed LCD | Novitas Solutions, Inc. |
L39063 | Pharmacogenomics Testing | LCD | Novitas Solutions, Inc. |
L36675 | ProMark® Risk Score | LCD | CGS Administrators, LLC |
L36704 | ProMark® Risk Score | LCD | Noridian Healthcare Solutions, LLC |
L36706 | ProMark® Risk Score | LCD | Noridian Healthcare Solutions, LLC |
L36665 | ProMark® Risk Score | LCD | Palmetto GBA |
L37011 | ProMark® Risk Score | LCD | Wisconsin Physicians Service Insurance Corporation |
L35075 | Proton Beam Therapy | LCD | National Government Services, Inc. |
L34520 | Psychological and Neuropsychological Tests | LCD | First Coast Service Options, Inc. |
A56247 | Response to Comments: Biomarker Testing for Neuroendocrine Tumors LCD L37851 | Article | National Government Services, Inc. |
A54998 | Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014. | Article | Noridian Healthcare Solutions, LLC |
A55031 | Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing Comment Period Ending 05/02/2014. | Article | Noridian Healthcare Solutions, LLC |
A55555 | Response to Comments: Diagnostic and Therapeutic Colonoscopy | Article | Noridian Healthcare Solutions, LLC |
A55558 | Response to Comments: Diagnostic and Therapeutic Colonoscopy | Article | Noridian Healthcare Solutions, LLC |
A58984 | Response to Comments: Genomic Sequence Analysis Panels in the Treatment of Solid Organ Neoplasms | Article | National Government Services, Inc. |
A54899 | Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment | Article | CGS Administrators, LLC |
A54988 | Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment | Article | CGS Administrators, LLC |
A56496 | Response to Comments: MolDX DecisionDx-Melanoma | Article | CGS Administrators, LLC |
A58198 | Response to Comments: MolDX Pharmacogenomics Testing (DL38435) | Article | Wisconsin Physicians Service Insurance Corporation |
A58072 | Response to Comments: MolDX Pigmented Lesion Assay | Article | Noridian Healthcare Solutions, LLC |
A58073 | Response to Comments: MolDX Pigmented Lesion Assay | Article | Noridian Healthcare Solutions, LLC |
A55540 | Response to Comments: MolDX-CDD: ConfirmMDx Epigenetic Molecular Assay (DL37005). | Article | Wisconsin Physicians Service Insurance Corporation |
A55398 | Response to Comments: MolDX-CDD: Decipher® Prostate Cancer Classifier Assay (L36791) | Article | Wisconsin Physicians Service Insurance Corporation |
A55396 | Response to Comments: MoLDX-CDD: Genomic Health™ Oncotype DX® Prostate Cancer Assay (L36789) | Article | Wisconsin Physicians Service Insurance Corporation |
A55452 | Response to Comments: MolDX: APC and MUTYH Gene | Article | CGS Administrators, LLC |
A55463 | Response to Comments: MolDX: APC and MUTYH Gene Testing | Article | Noridian Healthcare Solutions, LLC |
A55464 | Response to Comments: MolDX: APC and MUTYH Gene Testing | Article | Noridian Healthcare Solutions, LLC |
A55642 | Response to Comments: MolDX: APC and MUTYH Gene Testing (DL37224). | Article | Wisconsin Physicians Service Insurance Corporation |
A54978 | Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment | Article | Noridian Healthcare Solutions, LLC |
A54979 | Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment | Article | Noridian Healthcare Solutions, LLC |
A58452 | Response to Comments: MolDX: Blood Product Molecular Antigen Typing | Article | CGS Administrators, LLC |
A58505 | Response to Comments: MolDX: Blood Product Molecular Antigen Typing | Article | Noridian Healthcare Solutions, LLC |
A58506 | Response to Comments: MolDX: Blood Product Molecular Antigen Typing | Article | Noridian Healthcare Solutions, LLC |
A58306 | Response to Comments: MolDX: Blood Product Molecular Antigen Typing | Article | Palmetto GBA |
A58431 | Response to Comments: MolDX: Blood Product Molecular Antigen Typing (L38441) | Article | Wisconsin Physicians Service Insurance Corporation |
A56283 | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test | Article | CGS Administrators, LLC |
A56356 | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test | Article | Noridian Healthcare Solutions, LLC |
A56357 | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test | Article | Noridian Healthcare Solutions, LLC |
A56272 | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test | Article | Palmetto GBA |
A56338 | Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test (DL37913) | Article | Wisconsin Physicians Service Insurance Corporation |
A56230 | Response to Comments: MolDX: DecisionDx-Melanoma | Article | Noridian Healthcare Solutions, LLC |
A56231 | Response to Comments: MolDX: DecisionDx-Melanoma | Article | Noridian Healthcare Solutions, LLC |
A58514 | Response to Comments: MolDX: DecisionDX-Melanoma | Article | Wisconsin Physicians Service Insurance Corporation |
A56635 | Response to Comments: MolDX: DecisionDX-Melanoma (L38018) | Article | Wisconsin Physicians Service Insurance Corporation |
A55876 | Response to Comments: MolDX: EndoPredict Breast Cancer Gene Expression Test | Article | CGS Administrators, LLC |
A55793 | Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test | Article | Noridian Healthcare Solutions, LLC |
A55794 | Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test | Article | Noridian Healthcare Solutions, LLC |
A56148 | Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC) | Article | CGS Administrators, LLC |
A56091 | Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC) | Article | Noridian Healthcare Solutions, LLC |
A56092 | Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC) | Article | Noridian Healthcare Solutions, LLC |
A56107 | Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC) | Article | Wisconsin Physicians Service Insurance Corporation |
A54813 | Response to Comments: MolDX: HLA-DQB1 0602 Testing for Narcolepsy | Article | CGS Administrators, LLC |
A56354 | Response to Comments: MolDX: MDS FISH | Article | CGS Administrators, LLC |
A56446 | Response to Comments: MolDX: MDS FISH | Article | Noridian Healthcare Solutions, LLC |
A56447 | Response to Comments: MolDX: MDS FISH | Article | Noridian Healthcare Solutions, LLC |
A56329 | Response to Comments: MolDX: MDS FISH | Article | Palmetto GBA |
A56399 | Response to Comments: MolDX: MDS FISH (DL37772) | Article | Wisconsin Physicians Service Insurance Corporation |
A58480 | Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing | Article | CGS Administrators, LLC |
A58507 | Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing | Article | Noridian Healthcare Solutions, LLC |
A58508 | Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing | Article | Noridian Healthcare Solutions, LLC |
A58417 | Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing | Article | Palmetto GBA |
A58916 | Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer | Article | CGS Administrators, LLC |
A58953 | Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer | Article | Noridian Healthcare Solutions, LLC |
A58954 | Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer | Article | Noridian Healthcare Solutions, LLC |
A58915 | Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer | Article | Palmetto GBA |
A58930 | Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer (DL38835) | Article | Wisconsin Physicians Service Insurance Corporation |
A54547 | Response to Comments: MolDX: Molecular Diagnostic Tests (MDT) | Article | Noridian Healthcare Solutions, LLC |
A54552 | Response to Comments: MolDX: Molecular Diagnostic Tests (MDT) | Article | Noridian Healthcare Solutions, LLC |
A54553 | Response to Comments: MolDX: Molecular Diagnostic Tests (MDT) | Article | Noridian Healthcare Solutions, LLC |
A54554 | Response to Comments: MolDX: Molecular Diagnostic Tests (MDT) | Article | Noridian Healthcare Solutions, LLC |
A59007 | Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Article | CGS Administrators, LLC |
A59017 | Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Article | Noridian Healthcare Solutions, LLC |
A59018 | Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Article | Noridian Healthcare Solutions, LLC |
A59005 | Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Article | Palmetto GBA |
A59020 | Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Article | Wisconsin Physicians Service Insurance Corporation |
A58687 | Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Article | CGS Administrators, LLC |
A58778 | Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Article | Noridian Healthcare Solutions, LLC |
A58780 | Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Article | Noridian Healthcare Solutions, LLC |
A58675 | Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Article | Palmetto GBA |
A58703 | Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection | Article | Wisconsin Physicians Service Insurance Corporation |
A56161 | Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels | Article | CGS Administrators, LLC |
A56251 | Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels | Article | Noridian Healthcare Solutions, LLC |
A56255 | Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels | Article | Noridian Healthcare Solutions, LLC |
A56169 | Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (DL37764) | Article | Wisconsin Physicians Service Insurance Corporation |
A56427 | Response to Comments: MolDX: myPath Melanoma Assay | Article | CGS Administrators, LLC |
A56387 | Response to Comments: MolDX: myPath Melanoma Assay | Article | Noridian Healthcare Solutions, LLC |
A56388 | Response to Comments: MolDX: myPath Melanoma Assay | Article | Noridian Healthcare Solutions, LLC |
A56379 | Response to Comments: MolDX: myPath Melanoma Assay | Article | Palmetto GBA |
A56509 | Response to Comments: MolDX: myPath Melanoma Assay (DL37923) | Article | Wisconsin Physicians Service Insurance Corporation |
A57877 | Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Article | CGS Administrators, LLC |
A57894 | Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Article | Noridian Healthcare Solutions, LLC |
A57909 | Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Article | Noridian Healthcare Solutions, LLC |
A57836 | Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Article | Palmetto GBA |
A57876 | Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors | Article | CGS Administrators, LLC |
A57904 | Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors | Article | Noridian Healthcare Solutions, LLC |
A57906 | Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors | Article | Noridian Healthcare Solutions, LLC |
A57830 | Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors | Article | Palmetto GBA |
A57879 | Response to Comments: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (DL38176) | Article | Wisconsin Physicians Service Insurance Corporation |
A58178 | Response to Comments: MolDX: Pharmacogenomics Testing | Article | CGS Administrators, LLC |
A58237 | Response to Comments: MolDX: Pharmacogenomics Testing | Article | Noridian Healthcare Solutions, LLC |
A58238 | Response to Comments: MolDX: Pharmacogenomics Testing | Article | Noridian Healthcare Solutions, LLC |
A58157 | Response to Comments: MolDX: Pharmacogenomics Testing | Article | Palmetto GBA |
A57916 | Response to Comments: MolDX: Pigmented Lesion Assay | Article | CGS Administrators, LLC |
A57869 | Response to Comments: MolDX: Pigmented Lesion Assay | Article | Palmetto GBA |
A57979 | Response to Comments: MolDX: Pigmented Lesion Assay | Article | Wisconsin Physicians Service Insurance Corporation |
A57918 | Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Article | CGS Administrators, LLC |
A57866 | Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Article | Palmetto GBA |
A57935 | Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (L38168) | Article | Wisconsin Physicians Service Insurance Corporation |
A58735 | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Article | CGS Administrators, LLC |
A58748 | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Article | Noridian Healthcare Solutions, LLC |
A58749 | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Article | Noridian Healthcare Solutions, LLC |
A58729 | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Article | Palmetto GBA |
A58791 | Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer DL38684 | Article | Wisconsin Physicians Service Insurance Corporation |
A55566 | Response to Comments: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease | Article | CGS Administrators, LLC |
A55778 | Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy | Article | Noridian Healthcare Solutions, LLC |
A55779 | Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy | Article | Noridian Healthcare Solutions, LLC |
A58368 | Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Article | CGS Administrators, LLC |
A58509 | Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Article | Noridian Healthcare Solutions, LLC |
A58511 | Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Article | Noridian Healthcare Solutions, LLC |
A58344 | Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Article | Palmetto GBA |
A58450 | Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (DL38433) | Article | Wisconsin Physicians Service Insurance Corporation |
A58040 | Response to Comments: MolDX: Repeat Germline Testing | Article | CGS Administrators, LLC |
A58176 | Response to Comments: MolDX: Repeat Germline Testing | Article | Noridian Healthcare Solutions, LLC |
A58177 | Response to Comments: MolDX: Repeat Germline Testing | Article | Noridian Healthcare Solutions, LLC |
A58016 | Response to Comments: MolDX: Repeat Germline Testing | Article | Palmetto GBA |
A58118 | Response to Comments: MolDX: Repeat Germline Testing (L38429) | Article | Wisconsin Physicians Service Insurance Corporation |
A55564 | Response to Comments: MolDX: VitaRisk ™ Pharmacogenetic Test for Dry Age-related Macular Degeneration (AMD) | Article | CGS Administrators, LLC |
A55334 | Response to Comments: Molecular Pathology Procedures | Article | National Government Services, Inc. |
A55982 | Response to Comments: Molecular Pathology Procedures | Article | National Government Services, Inc. |
A54588 | Response to Comments: MoPath: Special Histochemical Stains and Immunohistochemical Stains | Article | CGS Administrators, LLC |
A57861 | Response to Comments: Next-Generation Sequencing for Solid Tumor (DL38158) | Article | Wisconsin Physicians Service Insurance Corporation |
A56058 | Response to Comments: Nusinersen (Spinraza) | Article | Novitas Solutions, Inc. |
A58922 | Response to Comments: Pharmacogenomics Testing | Article | First Coast Service Options, Inc. |
A58929 | Response to Comments: Pharmacogenomics Testing | Article | Novitas Solutions, Inc. |
A54586 | Response to Comments: Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II prothrombin, and MTHFR) | Article | CGS Administrators, LLC |
A59001 | Response to Comments: Treatment of Varicose Veins of the Lower Extremities | Article | Palmetto GBA |
A55475 | Response to Comments: Visual Electrophysiology Testing | Article | National Government Services, Inc. |
A56401 | Response to Comments: Voretigene Neparvovec-rzyl (Luxturna™) | Article | Palmetto GBA |
L35026 | Rituximab | LCD | Palmetto GBA |
DL38968 (Comments Ended 07/17/2021) | Thyroid Nodule Molecular Testing | Proposed LCD | National Government Services, Inc. |
L38968 | Thyroid Nodule Molecular Testing | LCD | National Government Services, Inc. |
L38720 | Treatment of Chronic Venous Insufficiency of the Lower Extremities | LCD | First Coast Service Options, Inc. |
L34924 | Treatment of Chronic Venous Insufficiency of the Lower Extremities | LCD | Novitas Solutions, Inc. |
L36538 | Treatment of Males with Low Testosterone | LCD | Noridian Healthcare Solutions, LLC |
L36569 | Treatment of Males with Low Testosterone | LCD | Noridian Healthcare Solutions, LLC |
DL39086 (Comments Ended 11/06/2021) | Treatment of Males with Low Testosterone | Proposed LCD | Palmetto GBA |
L39086 (Notice Ended 02/12/2022) | Treatment of Males with Low Testosterone | LCD | Palmetto GBA |
L35007 | Vestibular and Audiologic Function Studies | LCD | Novitas Solutions, Inc. |
L33767 | Viscosupplementation Therapy For Knee | LCD | First Coast Service Options, Inc. |
L37535 | Vitamin D Assay Testing | LCD | National Government Services, Inc. |
L34051 | Vitamin D Assay Testing | LCD | Noridian Healthcare Solutions, LLC |
L36692 | Vitamin D Assay Testing | LCD | Noridian Healthcare Solutions, LLC |
L37863 | Voretigene Neparvovec-rzyl (Luxturna®) | LCD | Palmetto GBA |
A52505 | Wheelchair Seating - Policy Article | Article | CGS Administrators, LLC, Noridian Healthcare Solutions, LLC |